Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000921895-24-002770
Filing Date
2024-11-18
Accepted
2024-11-18 17:23:52
Documents
2

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G sc13g07422verv_11182024.htm SC 13G 275264
2 JOINT FILING AGREEMENT ex991to13g07422verv_111824.htm EX-99.1 8422
  Complete submission text file 0000921895-24-002770.txt   285366
Mailing Address 44 MONTGOMERY STREET 40TH FL SAN FRANCISCO CA 94104
Business Address 44 MONTGOMERY STREET 40TH FL SAN FRANCISCO CA 94104 3125066500
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

EIN.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 6282 Investment Advice
(CF Office: 02 Finance)

Mailing Address 201 BROOKLINE AVENUE SUITE 601 BOSTON MA 02215
Business Address 201 BROOKLINE AVENUE SUITE 601 BOSTON MA 02215 (978) 501-3026
Verve Therapeutics, Inc. (Subject) CIK: 0001840574 (see all company filings)

EIN.: 824800132 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92605 | Film No.: 241472501
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)